Acasti Pharma Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (38)

Latest Posts

About This Stock More About This Stock
Generic Industry On Path To Recovery: 3 Hot Picks For 2019
Article By: Zacks Investment Research
Friday, December 28, 2018 7:35 PM EST
The Medical-Generic Drugs industry recovered somewhat in 2018 after a rough 2017, gaining from stabilization in U.S. generic drug pricing.This stability in the industry sets the stage for players to get back on growth track.
In this article: RDY, BHC, ACST Also: MYL, TEVA
Week In Review: China Renaissance Sets $7 Billion Goal For New VC/PE Funds, Including Biotech/Healthcare
Article By: ChinaBio® Today
Saturday, November 25, 2017 4:33 PM EST
China Renaissance, a Beijing investment bank and VC/PE investor, plans to expand its investment funds operations, climbing from $3 billion assets-under-management currently to $10 billion over the next three years.
In this article: ACST, SRNE, LIVN
Healthcare Review: CPRX, CANF, ACST, NWBO, ACT
Article By: BioMedReports
Wednesday, October 1, 2014 3:35 AM EST
The Dow Jones Industrial Average rose 37 points, or 0.2%, to 17108. The S&P 500 added four points, or 0.2%, to 1982, and the Nasdaq Composite Index rose six points, or 0.1%, to 4512.
In this article: NWBO, ACST, CPRX, ACT, CANF

Latest Tweets for $ACST

No tweets yet!